SCHEMBL1041196

SCHEMBL1041196

NC(=O)OC(Cl)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22729367 0.78 TP53 (0.30)
SCHEMBL9314301 0.76
SCHEMBL22729368 0.76
SCHEMBL14783931 0.76
SCHEMBL4297352 0.74
SCHEMBL5327693 0.74 TP53 (0.33)
SCHEMBL22556160 0.73
SCHEMBL8811111 0.72
SCHEMBL22556151 0.71 LMNA (0.37)
SCHEMBL7769672 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112538027-B Preparation and application of ginkgolic acid amide compound 江苏省中国科学院植物研究所 2022-08-26 CN claimed
EP-1777228-B1 Purification of béta-lactam products ACS DOBFAR SPA (IT) 2010-09-15 EP claimed
US-7728126-B2 Purification of beta-lactam products ACS DOBFAR S.P.A. (IT) 2010-06-01 US claimed
US-20070093657-A1 PURIFICATION OF BETA-LACTAM PRODUCTS ACS DOBFAR S.P.A. (IT) 2007-04-26 US claimed
EP-1777228-A1 Purification of béta-lactam products ACS DOBFAR S.p.A. (IT) 2007-04-25 EP claimed
US-20260109716-A1 CEREBLON-BASED KRAS DEGRADING PROTACS AND USES RELATED THERETO ARVINAS OPERATIONS, INC. (US) 2026-04-23 US disclosed
US-20260055097-A9 NRF2 PROTEIN DEGRADERS GANYMEDE ONCOLOGY INC (US) 2026-02-26 US disclosed
EP-4684874-A2 SORBENT COMPOSITIONS, SYSTEMS, AND METHODS GE Vernova Technology GmbH (CH) 2026-01-28 EP disclosed
EP-4681810-A1 SORBENT COMPOSITIONS, SYSTEMS, AND METHODS GE Vernova Technology GmbH (CH) 2026-01-21 EP disclosed
EP-4681811-A1 SORBENT COMPOSITIONS, SYSTEMS, AND METHODS GE Vernova Technology GmbH (CH) 2026-01-21 EP disclosed
US-12522628-B2 Aryl glucoside derivative and use thereof in drug SHANGHAI ZHEYE BIOTECHNOLOGY CO. LTD. (CN) 2026-01-13 US disclosed
US-20250375750-A1 SORBENT COMPOSITIONS, SYSTEMS, AND METHODS GE INFRASTRUCTURE TECHNOLOGY LLC (US) 2025-12-11 US disclosed
EP-0197949-A1 VITAMIN D DERIVATIVES AND METHODS FOR PREPARING SAME WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1986-10-22 EP disclosed
WO-1986002078-A1 VITAMIN D DERIVATIVES AND METHODS FOR PREPARING SAME WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1986-04-10 WO disclosed
EP-0114171-A1 Recovery of catalyst from olefin hydrocyanation and isomerization E.I. DU PONT DE NEMOURS AND COMPANY (US) 1984-08-01 EP disclosed
US-4452868-A ELECTROCHEMICAL CELLS GOULD INC. (US) 1984-06-05 US disclosed
US-4177289-A FUNGICIDES, HERBICIDES, BACTERICIDES EXXON RESEARCH & ENGINEERING CO. (US) 1979-12-04 US disclosed
US-4171449-A Addition of N,N-dichloro-N-acyl compounds to conjugated dienes and bis-N-chlorocrotyl carbamate products therefrom EXXON RESEARCH & ENGINEERING CO. (US) 1979-10-16 US disclosed
US-4170608-A REDUCTION, PESTICIDES EXXON RESEARCH & ENGINEERING CO. (US) 1979-10-09 US disclosed
US-4146557-A CHLORINATION, DECHLORINATION, ALKYLATION EXXON RESEARCH & ENGINEERING CO. (US) 1979-03-27 US disclosed